MetaCap

Elutia (ELUT) vs Greenland Mines (GRML)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Elutia (ELUT) has outperformed Greenland Mines (GRML) over the past year, gaining 52.6% versus a loss of 87.1%. Greenland Mines is the larger company by market cap ($44.3 million vs $40.0 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ELUT+52.56%GRML-87.08%
+117%+10%-97%
Nov 21, 20251 yearNov 20, 2026
ELUT-86.97%GRML-99.40%
+32%-37%-106%
Apr 25, 20225 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ELUT versus GRML key metrics
MetricELUTGRML
Share price$0.9001$2.99
Market cap$39.96M$44.31M
1-day change+11.12%+2.75%
YTD return+29.88%-79.31%
1-year return+52.56%-87.08%
5-year return-82.76%—
EPS (TTM)$-0.68$-9.74
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$12.29M—
Revenue growth (YoY)-15.03%—
Net income (latest FY)$53.38M$-10.55M
Gross margin53.66%—
Operating margin-218.91%—
Net margin434.23%—
52-week high$1.39$37.00
52-week low$0.50$2.75
Distance from 52-week high-35.01%-91.92%
Analyst consensusstrong_buynone
Avg. price target upside+455.49%+3578.93%
Average volume185.17K8.93M
Shares outstanding44.40M14.82M
Employees255
SectorHealth CareHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)Biotechnology: Biological Products (No Diagnostic Substances)

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • ELUT has outperformed GRML by 139.6 percentage points over the past year.

About Elutia

ELUT stock →

Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Women's Health and Cardiovascular.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 25 employees

About Greenland Mines

GRML stock →

Greenland Mines Ltd engages in the cell and gene therapy, and natural resources businesses. The company primarily explores palladium, gold, and platinum deposits.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 5 employees

ELUT vs GRML FAQ

Which is bigger, Elutia or Greenland Mines?

Greenland Mines (GRML) is larger, with a market capitalization of $44.31M compared with $39.96M for Elutia (ELUT).

Which stock has performed better over the past year, ELUT or GRML?

ELUT returned +52.56% over the past 12 months, compared with -87.08% for GRML (price return, excluding dividends). Past performance does not predict future results.

Are Elutia and Greenland Mines in the same industry?

Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.

More comparisons